×
About 678 results

ALLMedicine™ Liver Diseases Center

Research & Reviews  219 results

Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.
https://doi.org/10.1038/s41575-022-00617-7 10.1016/j.jhep.2017.11.024 10.1038/nrgastro.2014.155 10.4254/wjh.v12.i3.72 10.1111/j.1572-0241.2005.00263.x 10.1111/j.1478-3231.2010.02247.x 10.1002/hep.29582 10.1002/cld.1001 10.1177/2050640617705577 10.1080/17474124.2017.1309280 10.1016/j.jhepr.2020.100166 10.1038/ki.2009.128 10.1186/s12882-015-0002-z 10.1111/liv.13965 10.1111/j.1432-2277.2011.01360.x 10.1111/tri.12875 10.2215/CJN.00080605 10.1111/liv.14986 10.1002/cpt.1553 10.1016/0092-8674(94)90137-6 10.1002/hep.1840110619 10.1126/science.272.5266.1339 10.1681/ASN.2019030298 10.1016/j.ajhg.2018.03.013 10.1016/j.kint.2020.02.022 10.1016/j.ajhg.2016.05.004 10.1186/s13023-020-01585-4 10.1038/ejhg.2015.86 10.1038/ng833 10.1038/ng.3871 10.1016/j.ejmg.2021.104160 10.1038/ng1104 10.1038/ng1357 10.1172/JCI90129 10.1002/humu.23383 10.1073/pnas.1309438111 10.21037/atm-20-3318 10.1172/JCI76972 10.1152/ajpgi.00064.2006 10.1038/ncb754 10.1073/pnas.0610324104 10.1074/jbc.M510082200 10.1093/hmg/ddl404 10.1016/j.devcel.2009.06.016 10.1038/s41575-018-0075-9 10.1038/ncb3363 10.1002/hep.26554 10.3389/fphys.2017.00887 10.1146/annurev-biophys-050511-102312 10.1074/jbc.REV118.002804 10.1016/j.bbamcr.2013.04.001 10.2174/1389203716666150213160438 10.1016/j.semcdb.2014.12.001 10.1038/ng.860 10.1074/jbc.M107788200 10.1038/nrgastro.2012.254 10.1016/j.molmed.2014.01.003 10.1002/hep.24292 10.1146/annurev-pathmechdis-012418-013013 10.3748/wjg.v19.i35.5775 10.1053/j.gastro.2011.08.004 10.1371/journal.pone.0132295 10.1002/hep.1840400404 10.2353/ajpath.2007.070337 10.1002/path.2734 10.1002/dvdy.21520 10.1038/nature07753 10.1038/ki.2010.375 10.1016/j.cell.2011.05.030 10.1242/dev.054452 10.1242/dev.078634 10.1002/hep.21952 10.1186/2046-2530-1-7 10.1681/ASN.2006121355 10.1242/dev.129.8.1819 10.1016/j.ydbio.2007.05.028 10.1053/j.gastro.2005.12.005 10.1172/JCI0214099 10.1172/JCI200420083 10.1038/sj.emboj.7600160 10.1242/dev.02591 10.1053/j.gastro.2008.12.006 10.1016/S1665-2681(19)31406-1 10.1097/MOG.0000000000000514 10.1038/ejhg.2016.97 10.34067/KID.0002522020 10.1371/journal.pone.0050324 10.1136/gutjnl-2014-308062 10.3748/wjg.v19.i1.141 10.1681/ASN.V1071524 10.1016/S1097-2765(00)80135-5 10.1055/s-0036-1597817 10.1053/j.gastro.2006.07.003 10.2353/ajpath.2008.080125 10.1016/j.jhep.2016.10.032 10.1002/hep.22636 10.1053/j.gastro.2010.04.010 10.1016/j.jhep.2015.05.023 10.1053/j.gastro.2006.12.039 10.1002/hep.26140 10.1159/000450989 10.2174/1389200216666151103115454 10.1002/hep.29284 10.1136/gutjnl-2015-309458 10.1016/S0002-9440(10)62231-6 10.1111/j.1523-1755.2004.00952.x 10.1002/hep.21143 10.1152/ajpcell.00038.2007 10.1053/j.gastro.2009.09.005 10.1002/hep.23511 10.2353/ajpath.2008.070293 10.1093/ndt/gfq384 10.1371/journal.pone.0087660 10.1053/jhep.2002.34741 10.1002/hep.23386 10.1038/s41598-017-16686-7 10.3748/wjg.v12.i22.3496 10.17235/reed.2016.3980/2015 10.1152/ajprenal.00242.2012 10.1016/j.clinre.2018.03.009 10.1111/joim.12645 10.1038/nm935 10.1681/ASN.2004121090 10.1038/labinvest.2016.93 10.1159/000477664 10.1038/s41575-019-0125-y 10.1152/ajpgi.90265.2008 10.1073/pnas.0705964104 10.1083/jcb.201101005 10.1186/s13630-015-0021-1 10.1016/j.gastro.2003.09.001 10.1016/S0002-9440(10)63427-X 10.2353/ajpath.2010.090658 10.1002/path.5685 10.1038/ng.2715 10.1016/j.kint.2020.05.049 10.34067/KID.0001022019 10.1016/j.ajpath.2013.09.021 10.1016/j.cell.2014.03.061 10.1016/j.cell.2007.04.035 10.1016/j.ajpath.2013.11.027 10.1016/j.ajpath.2017.12.016 10.1002/hep.31216 10.1016/j.kint.2016.05.031 10.1074/jbc.M117.803775 10.1152/ajprenal.00186.2017 10.1086/368295 10.1111/liv.14485 10.1038/s41580-018-0068-0 10.1073/pnas.2007194118 10.1016/j.jhep.2020.09.010 10.1002/ueg2.12126 10.1002/hep.28933 10.1002/hep.29577 10.4161/auto.7.7.15822 10.1038/s41467-020-18794-x 10.1172/JCI93557 10.1242/dev.175596 10.1016/j.devcel.2010.01.011 10.1038/nbt.3294 10.1016/j.bbrc.2016.04.075 10.1038/s41598-018-30433-6 10.1038/nbt.3275 10.1136/gutjnl-2013-305281 10.1002/hep.28382 10.1016/j.cellimm.2015.01.018 10.1002/hep.24036 10.1007/s10620-007-0121-x 10.1016/j.crad.2019.08.009 10.4103/0366-6999.211882 10.1016/j.radcr.2021.04.066 10.1007/s11605-007-0376-8 10.1111/hepr.12560 10.1016/j.transproceed.2008.02.080 10.1111/liv.13041 10.1016/j.mayocp.2015.05.011 10.1111/j.1365-2036.2011.04923.x 10.1111/liv.12726 10.1016/j.cgh.2015.12.049 10.1016/j.cgh.2015.05.039 10.1053/j.gastro.2019.04.018 10.1053/j.gastro.2013.04.055 10.1136/bmjopen-2019-032620 10.2215/CJN.13661119 10.1007/s00330-017-5205-1 10.1111/apt.13301 10.1146/annurev-pharmtox-010818-021059 10.1016/j.jhep.2016.05.009 10.1111/1744-9987.12326 10.1681/ASN.2004080660 10.1093/ndt/gfi181 10.1073/pnas.0509694103 10.3748/wjg.v23.i30.5499 10.1056/NEJMoa0907419 10.1056/NEJMoa1003491 10.1681/ASN.2007050626 10.1016/j.jhep.2013.03.004 10.1097/MD.0000000000026797 10.1681/ASN.2012070650 10.1111/cge.13249 10.1007/s12072-021-10176-9 10.3389/fped.2017.00221 10.1152/ajprenal.00352.2017 10.1371/journal.pone.0081480 10.1152/ajpgi.00120.2020 10.1249/MSS.0000000000002251 10.1172/JCI34922 10.1016/j.jhepr.2021.100345 10.1681/ASN.2017050483 10.1016/S0140-6736(18)32782-X 10.1038/s41575-019-0156-4 10.1038/s41572-018-0047-y 10.1016/j.ydbio.2009.10.025 10.1002/hep.25872 10.1053/j.gastro.2011.11.036 10.1152/ajprenal.00460.2010 10.1111/j.1523-1755.2005.00395.x
Nature Reviews. Gastroenterology & Hepatology; Olaizola P, Rodrigues PM et. al.

May 14th, 2022 - Polycystic liver diseases (PLDs) are inherited genetic disorders characterized by progressive development of intrahepatic, fluid-filled biliary cysts (more than ten), which constitute the main cause of morbidity and markedly affect the quality of ...

An elevated FIB-4 score is not associated with cardiovascular events: a longitudinal an...
https://doi.org/10.1097/MEG.0000000000002377
European Journal of Gastroenterology & Hepatology; Loosen S, Luedde M et. al.

Apr 13th, 2022 - Liver diseases and cardiovascular diseases are closely associated. Noninvasive tests (NITs), such as the FIB-4 score, have been recommended by different guidelines to rule out advanced fibrosis and estimate the risk of liver-related outcomes in pa...

Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis...
https://doi.org/10.1111/bcp.15333
British Journal of Clinical Pharmacology; Kurata Y, Muraki S et. al.

Mar 27th, 2022 - Theophylline clearance is known to be reduced in patients with chronic liver diseases (CLDs) such as chronic hepatitis (CH) and liver cirrhosis (LC). The Child-Pugh (CP) score is generally used for pharmacokinetic evaluation, whilst a model for en...

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942457
Annals of Hepatology; Chauhan M, Nzeako I et. al.

Mar 27th, 2022 - Lower antibody (Ab) responses after SARS-CoV-2 vaccination have been reported in liver transplant (LT) recipients and those with chronic liver diseases (CLD). The role of a booster dose in those with poor responses to initial vaccination is not we...

see more →

Guidelines  3 results

Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance fo...
https://doi.org/10.1016/j.aohep.2021.100341
Annals of Hepatology; Cardoso AC, A Villela-Nogueira C et. al.

Mar 20th, 2021 - In 2015 the European Association for the Study of Liver Diseases (EASL) and the Asociación Latinoamericana para el Estudio del Hígado (ALEH) published a guideline for the use of non-invasive markers of liver disease. At that time, this guideline f...

EASL clinical practice guidelines for the management of occupational liver diseases.
https://doi.org/10.1111/liv.14349
Liver International : Official Journal of the Internation... Colombo M

Feb 23rd, 2020 - The Clinical Practice Guidelines (CPG) on Occupational Liver Diseases (OLD) of the European Association for the Study of the Liver (EASL) have been developed to increase awareness, recognition and improve management of patients with OLD. Indeed, a...

Optimization of the transition process of youth with liver disease in adulthood: A posi...
https://doi.org/10.1016/j.clinre.2019.07.018
Clinics and Research in Hepatology and Gastroenterology; Antonini TM, Girard M et. al.

Oct 1st, 2019 - Transition describes a progressive and highly coordinated process encompassing the transfer of a young patient from paediatric care to the adult-care system. Transfer of medical care for an adolescent to adult services is a complex and challenging...

see more →

Drugs  1 results see all →

News  48 results

Workplace Discrimination Common in Hepatology
https://www.medscape.com/viewarticle/963039

Nov 17th, 2021 - NEW YORK (Reuters Health) - Hepatologists, particularly women and racial/ethnic minorities, commonly experience discrimination in the workplace, according to a cross-sectional survey of members of the American Association for the Study of Liver Di...

New AASLD Guidelines Ask Us to Reconsider How We View Bleeding Risk in Cirrhosis
https://www.medscape.com/viewarticle/946425

Mar 4th, 2021 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Kudos to the American Association for the Study of Liver Disease...

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 13th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Semaglutide Shows Promise in NASH Phase 2 Study
https://www.medscape.com/viewarticle/940975

Nov 13th, 2020 - Almost 60% of patients with biopsy-confirmed nonalcoholic steatohepatitis and liver fibrosis showed resolution of NASH after treatment with semaglutide,according to a phase 2, double-blind, randomized, placebo-controlled trial published in the New...

Treating Liver Disease During COVID-19: New Recommendations
https://www.staging.medscape.com/viewarticle/930411

May 14th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

see more →